- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Sectors
Corporates swarm to Hive Ventures fund
Hive Ventures has secured Mitac-Synnex Group, Unitech Electronics and GMI Technology as limited partners in its $13.5m maiden fundraise and may launch a second fund next year.
Jul 16, 2021Kriya engineers $100m series B
Patient Square Capital has led a series B round for the Stanford-linked gene therapy developer, which previously collected $80.5m in May last year.
Jul 16, 2021Daily Deal Round Up: July 15, 2021
Clean medicine developer Genexa roped in Unilever for its $60m series A round while Krafton led storytelling platform developer Pratilipi's $48m series D.
Jul 15, 2021Dynacure sets sights on $107m IPO
The IGBMC spinout was set up by Satt Conectus and is now seeking a listing in the US with a price range of $15 to $17.
Jul 15, 2021Emerging Leaders Q&A – Andrea Course, Shell Ventures
Q&A with Andrea Course, venture principal, Shell Ventures
Jul 15, 2021SoftBank serves Yanolja with $1.7bn
Booking Holdings-backed online travel services provider Yanolja has raised capital from SoftBank Vision Fund 2 ahead of a planned initial public offering.
Jul 15, 2021Banma Technologies lands $465m
Alibaba and SAIC Motor helped provide fresh funding for the in-car system provider having formed it as a joint venture in 2015.
Jul 15, 2021Cybereason picks up $275m
Softbank helped the XDR cybersecurity software provider secure crossover financing at a valuation likely to have exceeded $3bn.
Jul 15, 2021Amplitude anticipates direct listing
Tencent-backed digital analytics software provider Amplitude has reportedly filed confidentially for a direct listing, weeks after raising cash at a $4bn valuation.
Jul 15, 2021M1 Finance manages $150 series E
SoftBank Vision Fund 2 led a round valuing the money management platform developer at $1.5bn, four months after its series D.
Jul 15, 2021Eli Lilly prompts billion-dollar Protomer acquisition
The price Eli Lilly is paying for protein drug developer and portfolio company Protomer could potentially top $1bn dependent on milestone payments.
Jul 15, 2021Dynacure sets sights on $107m IPO
Ionis Pharmaceuticals' stake in the muscular disease treatment developer will be cut in an offering set to raise between $95m and $107m.
Jul 15, 2021Featured Content
The CVC Funding Round DatabaseRealtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.The CVC Funding Round Database
Realtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.
CVC DirectoryFull details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.CVC Directory
Full details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
